Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials-Reference-Cited by-同舟云学术

Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials

Published:2021-06 Issue:6 Volume:205 Page:1689-1697
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

McKay Rana R.¹,Berchuck Jacob²,Kwak Lucia²,Xie Wanling²,Silver Rebecca²,Bubley Glenn J.³,Chang Peter K.³,Wagner Andrew³,Zhang Zhenwei²,Kibel Adam S.²,Taplin Mary-Ellen²

Affiliation:

1. University of California San Diego, La Jolla, California

2. Dana-Farber Cancer Institute, Boston, Massachusetts

3. Beth Israel Deaconess Medical Center, Boston, Massachusetts

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Staging Intensification Strategies Associated with Radical Prostatectomy for High-Risk Prostate Cancer: Efficacy Evaluation and Exploration of Novel Approaches;Cancers;2024-07-05

2. Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer;JCO Precision Oncology;2024-07

3. The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy;Urologic Oncology: Seminars and Original Investigations;2024-03

4. Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial;Cancer;2024-01

5. Neoadjuvant chemohormonal therapy before radical prostatectomy in high-risk prostate cancer: a mini-review;American Journal of Clinical and Experimental Urology;2024